Sign in

CIK 0001001233

  • Non-accelerated filer
  • Smaller reporting company

SANGAMO THERAPEUTICS, INC

Sign in to watch
Ticker
SGMOQ
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680359556
Phone
+1 510-970-6000
Business address
501 CANAL BLVD., RICHMOND, CA, 94084
Former names
SANGAMO BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-25 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Grant or award +120,000 833,405
2025-02-25 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Grant or award · Stock Option (Right to Buy) +560,000 560,000
2025-02-25 Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY Shares withheld for taxes −1,375 $0.96 $1K 694,842
2025-02-25 Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY Grant or award +120,000 814,842
2025-02-25 Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY Grant or award · Stock Option (Right to Buy) +560,000 560,000
2025-02-25 Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER Shares withheld for taxes −1,375 $0.96 $1K 691,803
2025-02-25 Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER Grant or award +120,000 811,803
2025-02-25 Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER Grant or award · Stock Option (Right to Buy) +560,000 560,000
2025-02-25 Macrae Sandy PRESIDENT, CEO AND DIRECTOR Shares withheld for taxes −10,663 $0.96 $10K 2,077,848
2025-02-25 Macrae Sandy PRESIDENT, CEO AND DIRECTOR Grant or award +375,000 2,452,848
2025-02-25 Macrae Sandy PRESIDENT, CEO AND DIRECTOR Grant or award · Stock Option (Right to Buy) +1,750,000 1,750,000
2025-02-24 Davis Gregory D Head of Research & Technology Shares withheld for taxes −705 $1.00 $705 166,865
2025-02-24 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Shares withheld for taxes −1,792 $1.00 $2K 714,918
2025-02-24 Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY Shares withheld for taxes −1,434 $1.00 $1K 696,217
2025-02-24 Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER Shares withheld for taxes −1,792 $1.00 $2K 693,178
2025-02-24 Macrae Sandy PRESIDENT, CEO AND DIRECTOR Shares withheld for taxes −7,488 $1.00 $7K 2,088,511
2025-01-22 Davis Gregory D Head of Research & Technology Shares withheld for taxes −30,456 $1.15 $35K 167,570
2025-01-22 Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY Shares withheld for taxes −129,549 $1.15 $149K 697,651
2025-01-22 Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER Shares withheld for taxes −129,593 $1.15 $149K 716,710
2025-01-22 Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER Shares withheld for taxes −129,242 $1.15 $149K 694,970

Page 5 of 9 · 165 trades